Document:

<Page>

                                                                    CONFIDENTIAL

                                                                  Exhibit 10.6.7

                                                          CONFIDENTIAL TREATMENT
                                    GTC Biotherapeutics, Inc. has requested that
                                the marked portions of this document be accorded
                                   confidential treatment pursuant to Rule 24b-2
                                   promulgated under the Securities Exchange Act

                                AMENDMENT NO. 14
                                       TO
                              COOPERATION AGREEMENT

     This is Amendment No. 14, effective September 6, 1997 to the Cooperation
Agreement dated September , 1988, as subsequently amended (the "Amended
Agreement") by and between Tufts University acting through its School of
Veterinary Medicine ("TUSVM") and Genzyme Transgenics Corporation ("GTC").

     GTC and TUSVM hereby further amend the Amended Agreement as follows:

     1.  The Budget for Year 5 of the Further Extended Term is attached hereto
as Exhibit I.

     2.  The first sentence of the definition of "Net Sales" as set forth in
Section 1 of the Amended Agreement is changed to read as follows:

     "NET SALES - means the `adjusted amount' billed from an arms-length sale to
     independent third parties of Transgenic Proteins, derived from animals
     which, as embryos, were micro-injected by TUSVM with a Genzyme gene
     construct as part of the Project, by (i) GTC or an Affiliate (`GTC Direct
     Net Sales') or (ii) a sublicensee or a distributor of GTC, or other
     non-Affiliate seller authorized by GTC to make such sales (individually or
     collectively, 'Indirect Net Sales'."

     3.  The definition of "Distributor Fees" as set forth in Section 1 of the
Amended Agreement is changed to read as follows:

     "DISTRIBUTOR FEES - means the income stream received by GTC or an Affiliate
     from a sublicensee or a distributor as a result of:

         (i)      license fees,
         (ii)     royalties, or
         (iii)    other compensation,

     and which derive from the sale or a percentage of the sale of Transgenic
     Proteins derived from animals which, as embryos, were micro-injected by
     TUSVM with a Genzyme gene construct as part of the project.

                                       -1-
<Page>

TUSVM-GTC Cooperation Agreement
Amendment 14

     4.  The expression "GTC Direct Net Sales" is substituted for the expression
"IG Direct Net Sales" wherever the same appears in the Amended Agreement.

     5.  Exhibit A is hereby amended to include Exhibit A-1 which is attached
hereto as Exhibit II.

     To the extent not inconsistent herewith, all of the remaining terms of the
Amended Agreement shall continue in full force and effect.

                             TUFTS UNIVERSITY

                             By:  Tufts University School of Veterinary Medicine

                                  By:    /s/ Philip G. Salem
                                     -------------------------------------------
                                         Philip G. Salem

                                  Title: Senior Director, University Development
                                         ---------------------------------------

                             GENZYME TRANSGENICS CORPORATION

                             By:      /s/ Carol A. Ziomek, Ph.d.
                                ------------------------------------------------

                             Title: Vice President, Development
                                   ---------------------------------------------

                                       -2-
<Page>

TUSVM-GTC Cooperation Agreement
Amendment 14

                   EXHIBIT I TO AMENDMENT 14: ESTIMATED BUDGET

                                                                       120 GOATS

                                                              (PER DIEM = $1.97)

                                    [****(*)]

TOTAL COST:                                                             $408,702

----------
(*) Confidential Treatment has been requested for the marked portion.

                                       -3-
<Page>

                                                                    CONFIDENTIAL

                           EXHIBIT II TO AMENDMENT 14

    EXHIBIT A-1: TUSVM'S TASKS DURING YEAR FIVE OF THE FURTHER EXTENDED TERM

     During year five (5) of the Further Extended Term, TUSVM will provide
adequate personnel and facilities for general husbandry and veterinary care;
breeding management and husbandry; record keeping; surgeries related to
microinjection of goat embryos; advanced embryo collection and transfer; semen
collection and processing; kidding and kid husbandry; and, general chores
related to the management of the GTC goat herd.

                                       -4-<Page>

                                                                    CONFIDENTIAL

                                                                  Exhibit 10.6.8

                                                          CONFIDENTIAL TREATMENT
                                    GTC Biotherapeutics, Inc. has requested that
                                the marked portions of this document be accorded
                                   confidential treatment pursuant to Rule 24b-2
                                   promulgated under the Securities Exchange Act

                                AMENDMENT NO. 16
                                       TO
                              COOPERATION AGREEMENT

This is Amendment No. 16, effective September 6, 2000 to the Cooperation
Agreement dated September 6, 1988, as subsequently amended (the "Amended
Agreement") by and between Tufts University acting through its School of
Veterinary Medicine ("TUSVM") and Genzyme Transgenics Corporation ("GTC").

     GTC and TUSVM hereby further amend the Amended Agreement as follows:

1.   The Further Extended Term is extended to September 5, 2001 ("Year 8").

2.   The Budget for Year 8 and Proposed Budget for Year 9 of the Further
     Extended Term is attached hereto as Exhibit 1.

3.   "Roles and Responsibilities of Dr. Sandra Ayers and Staff" is attached
     hereto as Exhibit II.

4.   It is the intent of the Parties that a new Agreement will be negotiated
     between the Parties to encapsulate in one document the most current
     research activities and the relevant terms and conditions.

     Such an agreement will supersede all prior amendments, including this
     Amendment 16.

To the extent not inconsistent herewith, all of the remaining terms of the
Amended Agreement shall continue in full force and effect.

TUFTS UNIVERSITY                            GENZYME TRANSGENICS CORPORATION

By:  /s/ Gerald C. Wodehouse                 By:  /s/ Carol A. Ziomek, Ph.D.
   ------------------------------------         --------------------------------
                                                  /s/ Sandra Nusinoff Lehrman
                                                --------------------------------

<Page>

                                                                    CONFIDENTIAL

                         TUFTS/GENZYME TRANSGENICS CORP.
                         Cooperative Services Agreement
                              Goat Herd Maintenance
               Project Year September 6, 2000 - September 5, 2001

 EXHIBIT I TO AMENDMENT 16: ESTIMATED BUDGET FOR HOUSING IN GOAT BARNS I AND II

<Table>
<Caption>
                                                           YEAR 8       YEAR 9
                                                         -----------------------
<S>                                                       <C>          <C>

                                    [****(*)]

TOTAL PROJECT COST                                        469,242      492,385
</Table>

----------
(*) Confidential Treatment has been requested for the marked portion.

<Page>

                                                                    CONFIDENTIAL

                                                   GENZYME TRANSGENICS
                                                   CORP 175 Crossing Boulevard
                                                   Framingham, MA 01701-9322
                                                   Tel 508-872-8400
                                                   Fax 508-370-3797

            ROLES AND RESPONSIBILITIES OF DR. SANDRA AYRES AND STAFF

Dr. Sandra Ayres will continue to serve as the Chief Veterinarian and Surgeon in
charge of goats owned or used in GTC's Collaborative Program with Tufts
University School of Veterinary Medicine and perform the mutually agreed duties
outlined below. She will continue to supervise the husbandry staff who will
provide the animal care and veterinary services also described below.

VETERINARY ACTIVITIES:

     -    Key liaison with GTC Principal Investigator, Dr. Esmail Bebhoodi

     -    Health monitoring, vaccination, testing and medical treatment (i.e.
          provide full service veterinary care) of goats in the herd to maintain
          healthy goats

     -    Surgical services for embryo/oocyte collection and transfer

     -    Assistance in delivery of kids from pregnant does as required

     -    Tissue collection for transgene analysis and methods evaluation and/or
          enhancement

     -    Autopsy and necropsy activities on goats that have died or been
          euthanized

     -    Ensure that appropriate record keeping, notebooks, IACUC approvals and
          procedures comply with GTC's requirements and are in compliance with
          TUSVM IACUC, USDA and AAALAC International guidelines where
          appropriate

     -    Author or co-author and review manuscripts describing the data
          resulting from the various veterinary/collaborative activities as
          appropriate

     -    Ensure appropriate training and supervision of staff to carry out the
          duties listed below

HUSBANDRY ACTIVITIES

     -    Procurement and testing of goats for addition to the herd

     -    Goat maintenance activities (feed, water, change bedding etc.)

     -    Daily observations of goats to detect earliest signs of disease and
          parturition

     -    Hormone administration as per agreed to schedule with GTC staff

     -    Heat detection, artificial insemination and breeding of goats as
          needed

<Page>

                                                                    CONFIDENTIAL

     -    Ultrasound detection of pregnancy and/or follicular status

     -    Kidding of pregnant does

     -    Milking of goats for feeding kids and sampling of milk as per GTC
          needs

     -    Assist GTC with or perform semen collection and freezing as required

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}]]